Losing just 90 minutes of sleep a night can increase women's risk of this chronic disease... after just six WEEKS
Experts from Columbia University believe a lack of sleep can increase stress on insulin-producing cells, causing them to fail.
This can put women at greater risk of developing type 2 diabetes. (Source: the Mail online | Health)
Source: the Mail online | Health - November 13, 2023 Category: Consumer Health News Source Type: news
Beyond insulin: Medi-Cal expands patient access to diabetes supplies
California's Medicaid program is making it easier for people with diabetes to obtain the supplies they need to manage their blood sugar. (Source: L.A. Times - Health)
Source: L.A. Times - Health - November 13, 2023 Category: Consumer Health News Authors: Angela Hart | KFF Health News Source Type: news
UnitedHealth to Add 8 Insulin Products to Reimbursement List UnitedHealth to Add 8 Insulin Products to Reimbursement List
UnitedHealth ' s pharmacy benefit manager unit said on Thursday it was adding eight insulin products to its reimbursement list that would limit out-of-pocket spend to $35 or less.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Science Reveals Link Between Obesity, Diabetes & Pancreatic Cancer Risk
FRIDAY, Nov. 10, 2023 -- Having high insulin levels may be more than tough to manage when you have diabetes: New research shows it also appears to raise the risk of pancreatic cancer.In the study, scientists found excessive insulin levels... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 10, 2023 Category: General Medicine Source Type: news
FDA Approves Zepbound, the Most Potent Weight Loss Drug Yet
Weight loss drugs have dominated the headlines over the past year, and now there’s a new medication that may be the most effective one yet.
On Nov. 11, the U.S. Food and Drug Administration (FDA) approved tirzepatide (which will be sold under the brand name Zepbound), to treat overweight and obesity. Made by Eli Lilly and Co., the drug is already approved, in different doses, for type 2 diabetes, as Mounjaro, and its effectiveness in those patients is due in part to its weight loss effects.
[time-brightcove not-tgx=”true”]
About 70% of Americans are overweight, with a body mass index (BMI) between ...
Source: TIME: Health - November 9, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Ozempic Can ’ t Fix America ’ s Obesity Crisis
What is obesity?
Some people will tell you it’s a fancy word for being fat; others might say it’s a slur that pathologizes bigger bodies. And yet others will insist it’s a moral failing—one of laziness and poor willpower.
[time-brightcove not-tgx=”true”]
For the past decade, however, the medical community has recognized that obesity is a chronic disease, much like cancer, diabetes, and high blood pressure. Obesity triples the risk of hospitalization due to COVID-19, is linked with hundreds of medical complications, and accounts for 4 million preventable deaths every year.
Obesi...
Source: TIME: Health - November 8, 2023 Category: Consumer Health News Authors: Fatima Cody Stanford and Simar Bajaj Tags: Uncategorized freelance Source Type: news
Synthetic yeast project unveils cells with 50% artificial DNA
A 17-year project to craft a synthetic genome for yeast cells has reached a watershed. Researchers revealed this week in 10 new papers that they have created designer versions of all yeast chromosomes and incorporated almost half of them into cells that can survive and reproduce. “It’s a milestone we have been working on for a long time,” says geneticist Jef Boeke of NYU Langone Health, director of the project.
“It’s a very impressive body of work,” says synthetic biologist Sanjay Vashee of the J. Craig Venter Institute, who wasn’t connected to any of the studies.
Researchers have tinkered with th...
Source: ScienceNOW - November 8, 2023 Category: Science Source Type: news
' Moving Targets': Adjusting GLP-1 Agonists and Insulin'Moving Targets': Adjusting GLP-1 Agonists and Insulin
GLP-1 agonists are not only for weight loss but also for patients with diabetes. Anne Peters, MD, discusses the importance of monitoring dosing between insulin and GLP-1 agonists.Medscape Diabetes & Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 8, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news
Get an 'artificial pancreas' on the NHS: 150,000 type 1 diabetes sufferers are set to get gadget hailed as the 'biggest breakthrough since discovery of insulin'
National Institute of Health and Care Excellence (NICE) chiefs recommend people in England and Wales can get a hybrid closed loop system if their type 1 diabetes is not adequately controlled. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2023 Category: Consumer Health News Source Type: news
Should We End Obesity?
It’s unusual for a medication to become a household name; even more uncommon for its branding to become, like Advil, shorthand for an entire class of products; and rarest of all, for it to change not just U.S. medicine, but U.S. culture.
Ozempic has done all three.
Approved in 2017 as a type 2 diabetes medication, Ozempic has largely made its name—and a fortune for its manufacturer, Novo Nordisk—as a weight-loss aid. Novo Nordisk knew early on that diabetes patients often lost weight on the drug, but even company executives couldn’t have guessed how widely it would eventually take off as both ...
Source: TIME: Health - November 7, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs feature healthscienceclimate Magazine TIME 2030 Wellbeing Source Type: news
Is salt really a new culprit in type 2 diabetes?
There is some evidence that increasing salt intake, as measured by sodium in urine may be linked to increased levels of the stress hormone cortisol. This has been linked to increased blood pressure and the reduced effectiveness of the hormone insulin. Insulin normally controls blood glucose levels and is a key part of how type 2 diabetes develops. However, evidence for this mechanism has only been shown in rats. (Source: The Economic Times)
Source: The Economic Times - November 4, 2023 Category: Consumer Health News Source Type: news
What my Patient Did to Prove the Establishment Wrong
Here at the Sears Institute for Anti-Aging Medicine, we are having great success alerting people to what I call “Syndrome Zero.”
If you haven’t heard of this condition, you’re not alone. But I call it the most urgent public health threat of our time.
Syndrome Zero is the fundamental base of almost every health issue we face today — including obesity, heart disease, cancer, Alzheimer’s, arthritis, high blood pressure, metabolic syndrome, diabetes, and even hip fractures.
It already afflicts billions of people on the planet — and within a matter of decades, it will see nearly every man, woman, and child in Amer...
Source: Al Sears, MD Natural Remedies - November 3, 2023 Category: Complementary Medicine Authors: Jacob Tags: Health Nutrition Source Type: news
Insulin Appears Less Heat-Sensitive Than Previously Thought Insulin Appears Less Heat-Sensitive Than Previously Thought
A new Cochrane Review based on published and unpublished data finds that unopened insulin can last for up to 6 months and at temperatures up to 25 °C (77°F).Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - November 3, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Nurse accused of killing 4 patients, injuring others with high doses of insulin
A Pennsylvania nurse who allegedly gave lethal doses of insulin to numerous patients at health care facilities has been charged with additional crimes (Source: ABC News: Health)
Source: ABC News: Health - November 2, 2023 Category: Consumer Health News Tags: Health Source Type: news
Study finds potential for weekly insulin injections in diabetes care
Weekly insulin injections may be the future of diabetic care and could replace daily insulin injections according to a study undertaken by the University of Surrey. A year-long phase three trial has shown that weekly injections of insulin icodec could be used to manage type 1 diabetes as effectively as daily basal insulin treatments. The... Read moreThe post Study finds potential for weekly insulin injections in diabetes care appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - November 2, 2023 Category: Nursing Authors: Carolyn Scott Tags: Diabetes insulin type 1 diabetes weekly insulin Source Type: news
